Records containing: Malignant Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases
-
CLINICAL_TRIALS study record update · 2026-04-23A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH BRAF-MUTANT MELANOMA AND OTHER SOLID TUMORS
-
CLINICAL_TRIALS study record update · 2026-04-20Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases
-
CLINICAL_TRIALS study record update · 2026-03-13An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-12-08A First in Human Phase 1 Open-Label, Multicenter, Dose Escalation and Expansion Study of DEG6498 in Patients With Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-23A TWO-PART, PHASE 1A/B, OPEN-LABEL, MULTICENTER TRIAL EVALUATING PHARMACOKINETICS, SAFETY AND EFFICACY OF PF 07284890 (ARRY 461) IN PARTICIPANTS WITH BRAF V600 MUTANT SOLID TUMORS WITH AND WITHOUT BRAIN INVOLVEMENT
-
CLINICAL_TRIALS study record update · 2024-12-18A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor in Subjects With HER2 Overexpressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-11-22Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center Cohort
-
CLINICAL_TRIALS study record update · 2023-11-09A Phase I Clinical Trial of IMMH-010 in Patients With Advanced Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-03-24VIP: Validation of the Italian Version of the Patient-Reported Outcomes - Common Terminology Criteria for Adverse Events (PRO-CTCAE): A Prospective Multicenter Observational Study on Different Cancer Types
-
CLINICAL_TRIALS study record update · 2022-04-07A Phase 1，Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BPI-421286 in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-05-11INT-SCART-001: A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer.
-
CLINICAL_TRIALS study record update · 2020-03-11A Randomized Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent (Niti-S Mira-Cover II Biliary Stent) to the Common Covered Metallic Biliary Stent.
-
CLINICAL_TRIALS study record update · 2020-03-11Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent(Niti-S Mira-Cover Biliary Stent ) to the Common Covered Metallic Biliary Stent(Niti-S Biliary Stent)
-
CLINICAL_TRIALS study record update · 2019-12-18The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
-
CLINICAL_TRIALS study record update · 2019-12-17NCI Community Cancer Center Pilot Program Patient Survey